Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.
Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, Lin TY, Lee BW, Kwan K, Kasim SM, Chan CY, Kaplan KM, Distefano DJ, Harmon AL, Golie A, Hartzel J, Xu J, Li S, Matthews H, Sadoff JC, Shaw A. Lau YL, et al. Among authors: huang lm. Vaccine. 2002 Jul 26;20(23-24):2942-9. doi: 10.1016/s0264-410x(02)00245-1. Vaccine. 2002. PMID: 12126906 Clinical Trial.
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.
Lau YL, Fan Leung T, Sirvan Cetin B, Cagri Dinleyici E, Huang LM, Halperin SA, Hsiao CC, Tapiero B, Tipton M, Campbell JD, Moerman L, Povey M, Bi D, Singh T; Rota-096 study group. Lau YL, et al. Among authors: huang lm. Vaccine. 2022 Mar 25;40(14):2184-2190. doi: 10.1016/j.vaccine.2022.02.065. Epub 2022 Feb 26. Vaccine. 2022. PMID: 35232596 Free article. Clinical Trial.
A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.
Lee CY, Tang RB, Huang FY, Tang H, Huang LM, Bock HL. Lee CY, et al. Among authors: huang fy, huang lm. Int J Infect Dis. 2002 Sep;6(3):202-9. doi: 10.1016/s1201-9712(02)90112-8. Int J Infect Dis. 2002. PMID: 12718836 Free article. Clinical Trial.
Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.
Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, Rajamohanan KP, Narayanan SN, Kirubakaran C, Rappaport R, Razmpour A, Gruber WC, Forrest BD; Pan-Asian CAIV-T Pediatric Efficacy Trial Network. Tam JS, et al. Among authors: huang lm. Pediatr Infect Dis J. 2007 Jul;26(7):619-28. doi: 10.1097/INF.0b013e31806166f8. Pediatr Infect Dis J. 2007. PMID: 17596805 Clinical Trial.
586 results